IL6 and melanoma: Interestingly, elevated serum IL‐6 was correlated with a poor prognosis in melanoma, while IL‐4 is thought to promote the proliferation and survival of several cancer cells (Gocheva et al., 2010; Jobe et al., 2018; Yu et al., 2019).